CeriBell (CBLL) vs InMode (INMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CeriBell (CBLL) has outperformed InMode (INMD) over the past year, gaining 99.0% versus a loss of 6.8%. CeriBell is the larger company by market cap ($879.6 million vs $805.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CBLL | INMD |
|---|---|---|
| Share price | $22.92 | $14.00 |
| Market cap | $879.63M | $805.33M |
| 1-day change | -2.39% | -0.11% |
| YTD return | +7.07% | -4.63% |
| 1-year return | +98.98% | -6.79% |
| 5-year return | — | -83.20% |
| P/E ratio (TTM) | — | 11.57 |
| Forward P/E | — | 10.20 |
| EPS (TTM) | $-1.76 | $1.21 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $25.63 | $16.74 |
| 52-week low | $10.85 | $12.72 |
| Distance from 52-week high | -10.56% | -16.40% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +24.65% | +15.54% |
| Average volume | 368.86K | 521.98K |
| Shares outstanding | 38.38M | 57.54M |
| Employees | 327 | 660 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CBLL has outperformed INMD by 105.8 percentage points over the past year.
About CeriBell
CBLL stock →CeriBell, Inc. operates as a medical technology company in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 327 employees
About InMode
INMD stock →InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 660 employees
CBLL vs INMD FAQ
Which is bigger, CeriBell or InMode?
CeriBell (CBLL) is larger, with a market capitalization of $879.63M compared with $805.33M for InMode (INMD).
Which stock has performed better over the past year, CBLL or INMD?
CBLL returned +98.98% over the past 12 months, compared with -6.79% for INMD (price return, excluding dividends). Past performance does not predict future results.
Are CeriBell and InMode in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.